CAPTRUST Financial Advisors
CCXI

CAPTRUST Financial Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,866
Closed -$96K – 4569
2022
Q2 		$96K Buy
3,866
+2,614
+209% +$57.6K ﹤0.01% 2227
2022
Q1 		$31K Sell
1,252
-2,652
-68% -$74.5K ﹤0.01% 3132
2021
Q4 		$142K Buy
3,904
+385
+11% +$13.5K ﹤0.01% 1900
2021
Q3 		$60K Buy
3,519
+175
+5% +$2.73K ﹤0.01% 2460
2021
Q2 		$45K Buy
3,344
+279
+9% +$6.87K ﹤0.01% 2584
2021
Q1 		$157K Buy
3,065
+15
+0.5% +$902 ﹤0.01% 1650
2020
Q4 		$189K Buy
3,050
+2,800
+1,120% +$160K ﹤0.01% 1209
2020
Q3 		$14K Sell
250
-2,800
-92% -$151K ﹤0.01% 2154
2020
Q2 		$177K Sell
3,050
-400
-12% -$21.8K ﹤0.01% 1091
2020
Q1 		$133K Buy
+3,450
New +$146K ﹤0.01% 1006
2019
Q4 		– Sell
-4,000
Closed -$27K – 1944
2019
Q3 		$27K Buy
4,000
+2,000
+100% +$15K ﹤0.01% 1216
2019
Q2 		$19K Buy
+2,000
New +$23.2K ﹤0.01% 1296

Other funds holding CCXI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

CAPTRUST Financial Advisors's CCXI Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 3,866 shares — an estimated $96K sold.

CAPTRUST Financial Advisors first reported a position in CCXI in Q2 2019 and held it in 12 quarters. The position peaked at $189K in Q4 2020. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 3,866 ChemoCentryx, Inc. shares in Q3 2022, an estimated $96K.
  • CAPTRUST Financial Advisors first reported a position in ChemoCentryx, Inc. in Q2 2019 and held it in 12 quarters.
  • CAPTRUST Financial Advisors's ChemoCentryx, Inc. position peaked at $189K in Q4 2020.
  • 217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.